Génome Québec supports Montreal Cancer Consortium (MCC)
Génome Québec is proud to take part in this initiative of the Terry Fox Research Institute, which will generate new advances in precision medicine. Research done by the participating institutions will seek to improve treatments for 18,000 cancer patients treated annually in Québec, particularly with the development of immunotherapy. “Génome Québec salutes this initiative that…